Publications on sEH-induced diseases studied using Detroit R&D BioTarget® Hypertension ELISA.
1. Spiecker et al. Risk of coronary artery disease associated with polymorphism of the cytochrome p450 epoxygenase CYP2J2. Circulation 110, 2132, 2004.
2. Kim et.al. Computational characterization of a series of eicosanoids. Lett. Drug Design & Discovery 2, 322-325. 2005Read More